EP
LMAT icon

Essential Partners’s LeMaitre Vascular LMAT Stock Holding History

Essential Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192 Hold
2
– – ﹤0.01% 2646
2026
Q1 		$218 Hold
2
– – ﹤0.01% 2589
2025
Q4 		$162 Hold
2
– – ﹤0.01% 2469
2025
Q3 		$175 Sell
2
-1
-33% -$89 ﹤0.01% 2417
2025
Q2 		$249 Buy
+3
New +$251 ﹤0.01% 1896

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Essential Partners's LMAT Position: Q2 2026 in Review

Essential Partners held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 2 shares worth $192. The position accounts for ﹤0.01% of the portfolio, ranked #2646.

Essential Partners first reported a position in LMAT in Q2 2025 and has held it in 5 quarters since. The position peaked at $249 in Q2 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Essential Partners held 2 shares of LeMaitre Vascular worth $192 as of Q2 2026.
  • Essential Partners left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2646 holding.
  • Essential Partners first reported a position in LeMaitre Vascular in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's LeMaitre Vascular position peaked at $249 in Q2 2025.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.